<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Your-Story.org &#187; Pharmeceuticals</title>
	<atom:link href="http://your-story.org/category/business/medical-pharmaceuticals/pharmeceuticals/feed/" rel="self" type="application/rss+xml" />
	<link>http://your-story.org</link>
	<description>The Press Release Resource</description>
	<lastBuildDate>Tue, 14 Feb 2012 21:18:37 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.1</generator>
		<item>
		<title>NEW DIRECTOR TAKES CHARGE OF BUSINESS SUPPORT ACTIVITY AT COLOPLAST IN PETERBOROUGH</title>
		<link>http://your-story.org/new-director-takes-charge-of-business-support-activity-at-coloplast-in-peterborough-303476/</link>
		<comments>http://your-story.org/new-director-takes-charge-of-business-support-activity-at-coloplast-in-peterborough-303476/#comments</comments>
		<pubDate>Wed, 25 Jan 2012 13:35:36 +0000</pubDate>
		<dc:creator>smyeholland</dc:creator>
				<category><![CDATA[Pharmeceuticals]]></category>

		<guid isPermaLink="false">http://your-story.org/?p=303476</guid>
		<description><![CDATA[Allan Kjer has been appointed as business support director at Peterborough-based medical devices company Coloplast. &#160; It is Danish-born Allan’s fourth job with the company. After working in finance jobs for Nordea Bank and Thomas Cook in Copenhagen he joined Coloplast as treasurer in 2006. His subsequent career with the company has seen him working ...]]></description>
		<wfw:commentRss>http://your-story.org/new-director-takes-charge-of-business-support-activity-at-coloplast-in-peterborough-303476/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>A Social Media Strategy in Times Square Boasts Great Results for TheraMax Cold and Flu</title>
		<link>http://your-story.org/a-social-media-strategy-in-times-square-boasts-great-results-for-theramax-cold-and-flu-299256/</link>
		<comments>http://your-story.org/a-social-media-strategy-in-times-square-boasts-great-results-for-theramax-cold-and-flu-299256/#comments</comments>
		<pubDate>Mon, 09 Jan 2012 19:39:27 +0000</pubDate>
		<dc:creator>Eclectic Media</dc:creator>
				<category><![CDATA[Pharmeceuticals]]></category>
		<category><![CDATA[allergy]]></category>
		<category><![CDATA[cold]]></category>
		<category><![CDATA[flu]]></category>
		<category><![CDATA[illness]]></category>
		<category><![CDATA[medication]]></category>
		<category><![CDATA[TheraMax]]></category>

		<guid isPermaLink="false">http://your-story.org/?p=299256</guid>
		<description><![CDATA[January 5, 2012 &#160; Contact: Megale Public Relations at (347) 92-STARS or (347) 927-8277 E Mail: info@mediaproductions.tv &#160; A Social Media Strategy in Times Square Boasts Great Results for TheraMax Cold and Flu (New York, NY) &#8211; TheraBiogen Inc. (TRAB:OTCBB), creator of TheraMaxtm Cold and Flu utilized the busy holiday season underneath their billboard in ...]]></description>
		<wfw:commentRss>http://your-story.org/a-social-media-strategy-in-times-square-boasts-great-results-for-theramax-cold-and-flu-299256/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Better Control, Healthier Yields: Biotech Process Analytical Technology</title>
		<link>http://your-story.org/better-control-healthier-yields-biotech-process-analytical-technology-280766/</link>
		<comments>http://your-story.org/better-control-healthier-yields-biotech-process-analytical-technology-280766/#comments</comments>
		<pubDate>Thu, 27 Oct 2011 09:04:53 +0000</pubDate>
		<dc:creator>Marie-Louise Hupert</dc:creator>
				<category><![CDATA[Pharmeceuticals]]></category>
		<category><![CDATA[accurate monitoring]]></category>
		<category><![CDATA[Applications Bioprocessing]]></category>
		<category><![CDATA[Applications in Fermentation]]></category>
		<category><![CDATA[Biotech Process Analytical Technology]]></category>
		<category><![CDATA[effective screening]]></category>
		<category><![CDATA[maximize batch yield]]></category>
		<category><![CDATA[optimize fermentation]]></category>
		<category><![CDATA[PAT]]></category>
		<category><![CDATA[Process Analytical Technology]]></category>
		<category><![CDATA[tight control of operating conditions]]></category>

		<guid isPermaLink="false">http://your-story.org/?p=280766</guid>
		<description><![CDATA[&#160; METTLER TOLEDO recently published a white paper entitled &#34;Process Analytical Technology (PAT) for Biotech: A Review of Recently Reported Applications in Fermentation and Bioprocessing.&#34; The paper explores how Process Analytical Technologies, or PATs, help optimize fermentation and bioprocess actions critical to pharmaceutical, specialty chemical, commodity chemical, and bulk fuel development and manufacturing. &#160; &#34;PAT ...]]></description>
		<wfw:commentRss>http://your-story.org/better-control-healthier-yields-biotech-process-analytical-technology-280766/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>EPM magazine appoints ELC GROUP as regular contributor</title>
		<link>http://your-story.org/epm-magazine-appoints-elc-group-as-regular-contributor-270183/</link>
		<comments>http://your-story.org/epm-magazine-appoints-elc-group-as-regular-contributor-270183/#comments</comments>
		<pubDate>Tue, 27 Sep 2011 14:21:23 +0000</pubDate>
		<dc:creator>neondrum</dc:creator>
				<category><![CDATA[Pharmeceuticals]]></category>
		<category><![CDATA[ELC Group]]></category>
		<category><![CDATA[Pharamaceutical manufacturing]]></category>
		<category><![CDATA[Pharamaceutical regulation]]></category>
		<category><![CDATA[pharmaceutical]]></category>
		<category><![CDATA[Regulatory Affairs]]></category>

		<guid isPermaLink="false">http://your-story.org/?p=270183</guid>
		<description><![CDATA[September 27th 2011 &#8211; ELC GROUP, the pan-European pharmaceutical regulatory affairs organisation, announced today that it would be working with the editorial team of European Pharmaceutical Manufacturer magazine to supply expert opinion on the regulatory affairs industry. ELC GROUP&#8217;s Advisory Board member, Dr. Paolo Biffignandi MD, PhD, QPPV, FTOPRA, will write the regular column. Dr. ...]]></description>
		<wfw:commentRss>http://your-story.org/epm-magazine-appoints-elc-group-as-regular-contributor-270183/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Global Genetic Testing Market Witnessing Effective Growth Momentum</title>
		<link>http://your-story.org/global-genetic-testing-market-witnessing-effective-growth-momentum-263200/</link>
		<comments>http://your-story.org/global-genetic-testing-market-witnessing-effective-growth-momentum-263200/#comments</comments>
		<pubDate>Fri, 26 Aug 2011 15:36:07 +0000</pubDate>
		<dc:creator>rncos</dc:creator>
				<category><![CDATA[Pharmeceuticals]]></category>
		<category><![CDATA[Global DTC Genetic Testing Market]]></category>
		<category><![CDATA[Global Genetic Testing Market]]></category>

		<guid isPermaLink="false">http://your-story.org/?p=263200</guid>
		<description><![CDATA[According to our latest report, “Global Genetic Testing Market Analysis”, with the total contribution of around 15%, the global genetic testing market represents one of the leading applications of molecular diagnostics. Genetic testing is currently available to assess the risk of developing a wide range of medical conditions and consumers’ preferences to opt or not ...]]></description>
		<wfw:commentRss>http://your-story.org/global-genetic-testing-market-witnessing-effective-growth-momentum-263200/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Clinical Data Management Spurring Growth of the Indian CT Industry</title>
		<link>http://your-story.org/clinical-data-management-spurring-growth-of-the-indian-ct-industry-262783/</link>
		<comments>http://your-story.org/clinical-data-management-spurring-growth-of-the-indian-ct-industry-262783/#comments</comments>
		<pubDate>Thu, 25 Aug 2011 13:15:03 +0000</pubDate>
		<dc:creator>rncos</dc:creator>
				<category><![CDATA[Pharmeceuticals]]></category>
		<category><![CDATA[India Clinical Trials by Type]]></category>
		<category><![CDATA[India Clinical Trials Market]]></category>
		<category><![CDATA[India Number of Clinical Trials]]></category>

		<guid isPermaLink="false">http://your-story.org/?p=262783</guid>
		<description><![CDATA[&#160; According to our latest research report, “Booming Clinical Trials Market in India”, the spending of pharma companies in CDM runs into millions of dollars. Typically, data management costs account for 20-35% of the total cost of a clinical trial. As CDM is highly technology-driven and needs the use of IT systems; hence, pharma companies ...]]></description>
		<wfw:commentRss>http://your-story.org/clinical-data-management-spurring-growth-of-the-indian-ct-industry-262783/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Stupendous Growth Observed in Global Genetic Testing Market</title>
		<link>http://your-story.org/stupendous-growth-observed-in-global-genetic-testing-market-258036/</link>
		<comments>http://your-story.org/stupendous-growth-observed-in-global-genetic-testing-market-258036/#comments</comments>
		<pubDate>Thu, 04 Aug 2011 09:42:34 +0000</pubDate>
		<dc:creator>rncos</dc:creator>
				<category><![CDATA[Pharmeceuticals]]></category>
		<category><![CDATA[Global Genetic Testing Industry]]></category>
		<category><![CDATA[Global Genetic Testing Market]]></category>
		<category><![CDATA[Global Genetic Testing Sector]]></category>

		<guid isPermaLink="false">http://your-story.org/?p=258036</guid>
		<description><![CDATA[According to our latest report entitled, &#8220;Global Genetic Testing Market Analysis&#8221;, global genetic testing market witnessed a rapid growth rate in the recent years on the back of factors, such as increasing awareness level, rising prevalence of genetic disorders, and private sector participation. Recent industry developments and discovery of new genes are attracting a large ...]]></description>
		<wfw:commentRss>http://your-story.org/stupendous-growth-observed-in-global-genetic-testing-market-258036/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Huge Opportunities for Indian Generics Drug Sector Ramping up in the US</title>
		<link>http://your-story.org/huge-opportunities-for-indian-generics-drug-sector-ramping-up-in-the-us-257068/</link>
		<comments>http://your-story.org/huge-opportunities-for-indian-generics-drug-sector-ramping-up-in-the-us-257068/#comments</comments>
		<pubDate>Mon, 01 Aug 2011 12:36:01 +0000</pubDate>
		<dc:creator>rncos</dc:creator>
				<category><![CDATA[Pharmeceuticals]]></category>
		<category><![CDATA[Counterfeit Drugs]]></category>
		<category><![CDATA[India Pharma]]></category>
		<category><![CDATA[India Pharma Market]]></category>
		<category><![CDATA[US Generics Market]]></category>

		<guid isPermaLink="false">http://your-story.org/?p=257068</guid>
		<description><![CDATA[According to our latest report, &#8220;Booming Generics Drug Market in India&#8221;, the Indian generics drug market has been growing at a rapid pace over the past few years. Despite the recession, the market continued to perform well and reached an estimated mark of US$ 17 Billion in FY 2010. Factors including patent expiries, increasing awareness ...]]></description>
		<wfw:commentRss>http://your-story.org/huge-opportunities-for-indian-generics-drug-sector-ramping-up-in-the-us-257068/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Indian Biosimilars Industry Poised for Immense Growth</title>
		<link>http://your-story.org/indian-biosimilars-industry-poised-for-immense-growth-255746/</link>
		<comments>http://your-story.org/indian-biosimilars-industry-poised-for-immense-growth-255746/#comments</comments>
		<pubDate>Tue, 26 Jul 2011 10:33:13 +0000</pubDate>
		<dc:creator>rncos</dc:creator>
				<category><![CDATA[Pharmeceuticals]]></category>
		<category><![CDATA[Global Biosimilars Market]]></category>
		<category><![CDATA[Global Erythropoietin Market]]></category>
		<category><![CDATA[US Biosimilars Market]]></category>

		<guid isPermaLink="false">http://your-story.org/?p=255746</guid>
		<description><![CDATA[As per our new research report, “Global Biosimilars Market Analysis”, the acceptability of biosimilars is very high in the Indian domestic market. Factors that are working favorably for Indian biosimilar companies are the relative cost advantage of biosimilar development compared to their competitors elsewhere; hence reducing appeal of imported biosimilars and relatively lowering of regulatory ...]]></description>
		<wfw:commentRss>http://your-story.org/indian-biosimilars-industry-poised-for-immense-growth-255746/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Asian Medical Tourism Market to Grow at 20% CAGR</title>
		<link>http://your-story.org/asian-medical-tourism-market-to-grow-at-20-cagr-255341/</link>
		<comments>http://your-story.org/asian-medical-tourism-market-to-grow-at-20-cagr-255341/#comments</comments>
		<pubDate>Mon, 25 Jul 2011 18:58:08 +0000</pubDate>
		<dc:creator>rncos</dc:creator>
				<category><![CDATA[Pharmeceuticals]]></category>
		<category><![CDATA[Asia Spa Market]]></category>
		<category><![CDATA[Asia Wellness Tourism]]></category>
		<category><![CDATA[India Spa Market]]></category>

		<guid isPermaLink="false">http://your-story.org/?p=255341</guid>
		<description><![CDATA[According to our new research report, “Asian Medical Tourism Analysis (2008-2012)”,&#160; medical tourism is emerging as one of the fastest growing markets in Asia, with the rising number of foreign tourists coming for their treatments into the region. The main reasons for the growth of the industry include the low cost of treatments and the ...]]></description>
		<wfw:commentRss>http://your-story.org/asian-medical-tourism-market-to-grow-at-20-cagr-255341/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Government Intervention to Ensure Russian Pharma Market Growth</title>
		<link>http://your-story.org/government-intervention-to-ensure-russian-pharma-market-growth-255326/</link>
		<comments>http://your-story.org/government-intervention-to-ensure-russian-pharma-market-growth-255326/#comments</comments>
		<pubDate>Mon, 25 Jul 2011 18:58:04 +0000</pubDate>
		<dc:creator>rncos</dc:creator>
				<category><![CDATA[Pharmeceuticals]]></category>
		<category><![CDATA[Parapharmaceutical Market]]></category>
		<category><![CDATA[Parapharmaceutical Segment]]></category>
		<category><![CDATA[Russian Pharma Industry]]></category>

		<guid isPermaLink="false">http://your-story.org/?p=255326</guid>
		<description><![CDATA[According to our latest research report, “Russian Pharma Sector Forecast to 2013”, the Government and other industrial regulatory bodies are taking numerous initiatives to ensure that the pharma industry in the country receives tremendous boost for the future. Understanding the pressing situation put forth by rising prevalence of lifestyle disease, such as diabetes, hypertension, cardiovascular ...]]></description>
		<wfw:commentRss>http://your-story.org/government-intervention-to-ensure-russian-pharma-market-growth-255326/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>RNCOS Publishes a New Company Report &#8211; Rite Aid Corporation</title>
		<link>http://your-story.org/rncos-publishes-a-new-company-report-rite-aid-corporation-253999/</link>
		<comments>http://your-story.org/rncos-publishes-a-new-company-report-rite-aid-corporation-253999/#comments</comments>
		<pubDate>Tue, 19 Jul 2011 14:23:47 +0000</pubDate>
		<dc:creator>rncos</dc:creator>
				<category><![CDATA[Pharmeceuticals]]></category>
		<category><![CDATA[Key Ratios Market]]></category>
		<category><![CDATA[research reports]]></category>
		<category><![CDATA[SWOT Analysis]]></category>

		<guid isPermaLink="false">http://your-story.org/?p=253999</guid>
		<description><![CDATA[RNCOS has recently published “Rite Aid Corporation &#8211; Company Analysis” The study provides an overview of the company’s history, businesses, its mergers and acquisitions, etc. It provides an insight into the products and services offered by the company for informing prospective clients about its product portfolio. The report also provides comprehensive financial information about the ...]]></description>
		<wfw:commentRss>http://your-story.org/rncos-publishes-a-new-company-report-rite-aid-corporation-253999/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Oral Diabetic Drug Market in China Surging High</title>
		<link>http://your-story.org/oral-diabetic-drug-market-in-china-surging-high-253685/</link>
		<comments>http://your-story.org/oral-diabetic-drug-market-in-china-surging-high-253685/#comments</comments>
		<pubDate>Mon, 18 Jul 2011 11:18:38 +0000</pubDate>
		<dc:creator>rncos</dc:creator>
				<category><![CDATA[Pharmeceuticals]]></category>
		<category><![CDATA[China Diabetes Market]]></category>
		<category><![CDATA[China Diabetes Report]]></category>
		<category><![CDATA[China Diabetes Sector]]></category>

		<guid isPermaLink="false">http://your-story.org/?p=253685</guid>
		<description><![CDATA[The prevalence of diabetes is less in China compared to other developed and developing nations, but as it houses the largest population in the world, it provides plethora of opportunities to the pharmaceutical players entering in this market. Besides, amid increasing concerns towards health and increasing awareness about chronic diseases, like diabetes among the consumers, ...]]></description>
		<wfw:commentRss>http://your-story.org/oral-diabetic-drug-market-in-china-surging-high-253685/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>RNCOS Publishes a New Company Report &#8211; Ranbaxy Laboratories Limited</title>
		<link>http://your-story.org/rncos-publishes-a-new-company-report-ranbaxy-laboratories-limited-253671/</link>
		<comments>http://your-story.org/rncos-publishes-a-new-company-report-ranbaxy-laboratories-limited-253671/#comments</comments>
		<pubDate>Mon, 18 Jul 2011 11:18:26 +0000</pubDate>
		<dc:creator>rncos</dc:creator>
				<category><![CDATA[Pharmeceuticals]]></category>
		<category><![CDATA[Key Ratios Market]]></category>
		<category><![CDATA[research reports]]></category>
		<category><![CDATA[SWOT Analysis]]></category>

		<guid isPermaLink="false">http://your-story.org/?p=253671</guid>
		<description><![CDATA[RNCOS has recently published “Ranbaxy Laboratories Limited &#8211; Company Analysis” The study provides an overview of the company’s history, businesses, its mergers and acquisitions, etc. It provides an insight into the products and services offered by the company for informing prospective clients about its product portfolio. The report also provides comprehensive financial information about the ...]]></description>
		<wfw:commentRss>http://your-story.org/rncos-publishes-a-new-company-report-ranbaxy-laboratories-limited-253671/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>RNCOS Publishes a New Company Report &#8211; Bayer AG</title>
		<link>http://your-story.org/rncos-publishes-a-new-company-report-bayer-ag-252928/</link>
		<comments>http://your-story.org/rncos-publishes-a-new-company-report-bayer-ag-252928/#comments</comments>
		<pubDate>Thu, 14 Jul 2011 11:32:57 +0000</pubDate>
		<dc:creator>rncos</dc:creator>
				<category><![CDATA[Pharmeceuticals]]></category>
		<category><![CDATA[Bayer AG - Company Analysis]]></category>
		<category><![CDATA[Key Ratios Market]]></category>
		<category><![CDATA[research reports]]></category>

		<guid isPermaLink="false">http://your-story.org/?p=252928</guid>
		<description><![CDATA[RNCOS has recently published “Bayer AG &#8211; Company Analysis” The study provides an overview of the company’s history, businesses, its mergers and acquisitions, etc. It provides an insight into the products and services offered by the company for informing prospective clients about its product portfolio. The report also provides comprehensive financial information about the company ...]]></description>
		<wfw:commentRss>http://your-story.org/rncos-publishes-a-new-company-report-bayer-ag-252928/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Proton Pump Inhibitors to Boost the US Generics Market</title>
		<link>http://your-story.org/proton-pump-inhibitors-to-boost-the-us-generics-market-252698/</link>
		<comments>http://your-story.org/proton-pump-inhibitors-to-boost-the-us-generics-market-252698/#comments</comments>
		<pubDate>Wed, 13 Jul 2011 12:07:27 +0000</pubDate>
		<dc:creator>rncos</dc:creator>
				<category><![CDATA[Pharmeceuticals]]></category>
		<category><![CDATA[Antipsychotics Generic US]]></category>
		<category><![CDATA[Generics Market US]]></category>
		<category><![CDATA[Insulin Market US]]></category>

		<guid isPermaLink="false">http://your-story.org/?p=252698</guid>
		<description><![CDATA[The US generics market has shown a solid growth during the past few years backed by factors, such as government support, increasing awareness level, patent expiry of blockbuster drugs, price differences, and aging population. The generic drugs industry in the US stood at US$ 74 Billion in 2009, and is likely to grow further at ...]]></description>
		<wfw:commentRss>http://your-story.org/proton-pump-inhibitors-to-boost-the-us-generics-market-252698/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>US e-Health Market to Grow 12.8% CAGR by 2015</title>
		<link>http://your-story.org/us-e-health-market-to-grow-12-8-cagr-by-2015-251121/</link>
		<comments>http://your-story.org/us-e-health-market-to-grow-12-8-cagr-by-2015-251121/#comments</comments>
		<pubDate>Wed, 06 Jul 2011 12:26:27 +0000</pubDate>
		<dc:creator>rncos</dc:creator>
				<category><![CDATA[Pharmeceuticals]]></category>
		<category><![CDATA[US e-Health Industry]]></category>
		<category><![CDATA[US e-Health Market]]></category>
		<category><![CDATA[US e-Health Sector]]></category>

		<guid isPermaLink="false">http://your-story.org/?p=251121</guid>
		<description><![CDATA[According to our research “US e-health Market Analysis”, e-Health market has evolved as one of the fastest growing industries in the US during the last few years. The market has strongly benefited from the government’s strong desire to diminish the massive healthcare expenditures. Infact, e-Health being the most prominent source of cost containment is being ...]]></description>
		<wfw:commentRss>http://your-story.org/us-e-health-market-to-grow-12-8-cagr-by-2015-251121/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Unique Tonometer DIATON Presented at Optometry’s Meeting AOA/AOSA to 1000’s of Optometrists. Non-corneal DIATON Tonometry Revolutionizes Glaucoma Testing.</title>
		<link>http://your-story.org/unique-tonometer-diaton-presented-at-optometry%e2%80%99s-meeting-aoaaosa-to-1000%e2%80%99s-of-optometrists-non-corneal-diaton-tonometry-revolutionizes-glaucoma-testing-250183/</link>
		<comments>http://your-story.org/unique-tonometer-diaton-presented-at-optometry%e2%80%99s-meeting-aoaaosa-to-1000%e2%80%99s-of-optometrists-non-corneal-diaton-tonometry-revolutionizes-glaucoma-testing-250183/#comments</comments>
		<pubDate>Fri, 01 Jul 2011 08:15:12 +0000</pubDate>
		<dc:creator>sretreat</dc:creator>
				<category><![CDATA[Pharmeceuticals]]></category>
		<category><![CDATA[diaton]]></category>
		<category><![CDATA[eyecare]]></category>
		<category><![CDATA[glaucoma]]></category>
		<category><![CDATA[handheld]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[iop]]></category>
		<category><![CDATA[lasik]]></category>
		<category><![CDATA[ophthalmology]]></category>
		<category><![CDATA[optometry]]></category>
		<category><![CDATA[pen]]></category>
		<category><![CDATA[tono]]></category>
		<category><![CDATA[tonometer]]></category>
		<category><![CDATA[tonometry]]></category>
		<category><![CDATA[Vision]]></category>

		<guid isPermaLink="false">http://your-story.org/?p=250183</guid>
		<description><![CDATA[The only non-corneal and non-contact  Tonometer DIATON now enables optometrists and other healthcare professionals who provide primary vision care to test intraocular pressure (IOP) for glaucoma Through the EYELID. Quick and painless, handheld Diaton pen-like tonometer readings are not affected by contact lenses or other corneal properties. BiCOM Inc., home of tonometer Diaton is proud ...]]></description>
		<wfw:commentRss>http://your-story.org/unique-tonometer-diaton-presented-at-optometry%e2%80%99s-meeting-aoaaosa-to-1000%e2%80%99s-of-optometrists-non-corneal-diaton-tonometry-revolutionizes-glaucoma-testing-250183/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Rural Healthcare to Drive the Global Telemedicine Industry</title>
		<link>http://your-story.org/rural-healthcare-to-drive-the-global-telemedicine-industry-249582/</link>
		<comments>http://your-story.org/rural-healthcare-to-drive-the-global-telemedicine-industry-249582/#comments</comments>
		<pubDate>Wed, 29 Jun 2011 11:14:08 +0000</pubDate>
		<dc:creator>rncos</dc:creator>
				<category><![CDATA[Pharmeceuticals]]></category>
		<category><![CDATA[EU Telemedicine Market]]></category>
		<category><![CDATA[Japan Telemedicine Market]]></category>
		<category><![CDATA[US Telemedicine Market]]></category>

		<guid isPermaLink="false">http://your-story.org/?p=249582</guid>
		<description><![CDATA[As per our new research report “Global Telemedicine Market Analysis”, rural areas in most of the countries face various problems in the provision of medical services and health care, including funds, expertise, and resources. To meet this challenge, the governments and private health care providers are making use of existing resources and the benefits of ...]]></description>
		<wfw:commentRss>http://your-story.org/rural-healthcare-to-drive-the-global-telemedicine-industry-249582/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Joint Ventures in Generics Segment to Boost Indian Pharma Industry</title>
		<link>http://your-story.org/joint-ventures-in-generics-segment-to-boost-indian-pharma-industry-247506/</link>
		<comments>http://your-story.org/joint-ventures-in-generics-segment-to-boost-indian-pharma-industry-247506/#comments</comments>
		<pubDate>Fri, 17 Jun 2011 11:18:33 +0000</pubDate>
		<dc:creator>rncos</dc:creator>
				<category><![CDATA[Pharmeceuticals]]></category>
		<category><![CDATA[Formulations Market]]></category>
		<category><![CDATA[India Pharma]]></category>
		<category><![CDATA[Indian Pharmaceutical Market]]></category>

		<guid isPermaLink="false">http://www.your-story.org/?p=247506</guid>
		<description><![CDATA[According to our research report “Indian Pharma Sector Forecast 2014”, the Indian pharmaceutical industry is moving towards the adoption and development of generic drugs, which will help it to grow at a CAGR of around 15% during FY 2012-FY 2014. Despite factors, such as increasing urbanization and personal disposable income, a large share of people ...]]></description>
		<wfw:commentRss>http://your-story.org/joint-ventures-in-generics-segment-to-boost-indian-pharma-industry-247506/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Preparing a Paediatric Investigation Plan</title>
		<link>http://your-story.org/preparing-a-paediatric-investigation-plan-246385/</link>
		<comments>http://your-story.org/preparing-a-paediatric-investigation-plan-246385/#comments</comments>
		<pubDate>Tue, 07 Jun 2011 18:35:23 +0000</pubDate>
		<dc:creator>smigroup</dc:creator>
				<category><![CDATA[Pharmeceuticals]]></category>
		<category><![CDATA[commission]]></category>
		<category><![CDATA[effective]]></category>
		<category><![CDATA[European]]></category>
		<category><![CDATA[investigation]]></category>
		<category><![CDATA[law]]></category>
		<category><![CDATA[paediatric]]></category>
		<category><![CDATA[patent]]></category>
		<category><![CDATA[Plan]]></category>
		<category><![CDATA[preparation]]></category>
		<category><![CDATA[Process]]></category>
		<category><![CDATA[regulations]]></category>
		<category><![CDATA[treatments]]></category>

		<guid isPermaLink="false">http://www.your-story.org/?p=246385</guid>
		<description><![CDATA[The European Commission proposed the implementation of Paediatric Investigation Plans (PIPs) to help ensure that treatments for children are included in the mainstream drug development process in Europe, rather than as an elective extra. SMi Group provides a CPD accredited Masterclass which aims to address the problems encountered during the creation of a PIP, as ...]]></description>
		<wfw:commentRss>http://your-story.org/preparing-a-paediatric-investigation-plan-246385/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Preparing the Development Safety Update Report</title>
		<link>http://your-story.org/preparing-the-development-safety-update-report-2-246384/</link>
		<comments>http://your-story.org/preparing-the-development-safety-update-report-2-246384/#comments</comments>
		<pubDate>Tue, 07 Jun 2011 18:35:21 +0000</pubDate>
		<dc:creator>smigroup</dc:creator>
				<category><![CDATA[Pharmeceuticals]]></category>
		<category><![CDATA[compliance]]></category>
		<category><![CDATA[confidentiality]]></category>
		<category><![CDATA[development]]></category>
		<category><![CDATA[Drug]]></category>
		<category><![CDATA[Legal]]></category>
		<category><![CDATA[periodic]]></category>
		<category><![CDATA[Pharma]]></category>
		<category><![CDATA[regulators]]></category>
		<category><![CDATA[regulatory]]></category>
		<category><![CDATA[safety]]></category>
		<category><![CDATA[trial]]></category>
		<category><![CDATA[update]]></category>

		<guid isPermaLink="false">http://www.your-story.org/?p=246384</guid>
		<description><![CDATA[The CIOMS VII Working Group is proposing an internationally harmonised document, the Development Safety Update Report (DSUR) to streamline the process by which drug trial safety is monitored, which should improve patient safety, especially during a time when the effectiveness of a treatment is uncertain. The reason behind this is due to the fact that ...]]></description>
		<wfw:commentRss>http://your-story.org/preparing-the-development-safety-update-report-2-246384/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Preparing the Development Safety Update Report</title>
		<link>http://your-story.org/preparing-the-development-safety-update-report-246383/</link>
		<comments>http://your-story.org/preparing-the-development-safety-update-report-246383/#comments</comments>
		<pubDate>Tue, 07 Jun 2011 18:35:19 +0000</pubDate>
		<dc:creator>smigroup</dc:creator>
				<category><![CDATA[Pharmeceuticals]]></category>
		<category><![CDATA[compliance]]></category>
		<category><![CDATA[confidentiality]]></category>
		<category><![CDATA[development]]></category>
		<category><![CDATA[Drug]]></category>
		<category><![CDATA[Legal]]></category>
		<category><![CDATA[periodic]]></category>
		<category><![CDATA[Pharma]]></category>
		<category><![CDATA[regulators]]></category>
		<category><![CDATA[regulatory]]></category>
		<category><![CDATA[safety]]></category>
		<category><![CDATA[trial]]></category>
		<category><![CDATA[update]]></category>

		<guid isPermaLink="false">http://www.your-story.org/?p=246383</guid>
		<description><![CDATA[The CIOMS VII Working Group is proposing an internationally harmonised document, the Development Safety Update Report (DSUR) to streamline the process by which drug trial safety is monitored, which should improve patient safety, especially during a time when the effectiveness of a treatment is uncertain. The reason behind this is due to the fact that ...]]></description>
		<wfw:commentRss>http://your-story.org/preparing-the-development-safety-update-report-246383/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Social Media: Our Past Present and the Future of Digital Health Online</title>
		<link>http://your-story.org/social-media-our-past-present-and-the-future-of-digital-health-online-246382/</link>
		<comments>http://your-story.org/social-media-our-past-present-and-the-future-of-digital-health-online-246382/#comments</comments>
		<pubDate>Tue, 07 Jun 2011 18:35:17 +0000</pubDate>
		<dc:creator>smigroup</dc:creator>
				<category><![CDATA[Pharmeceuticals]]></category>
		<category><![CDATA[Advertising]]></category>
		<category><![CDATA[Branding Strategy]]></category>
		<category><![CDATA[Digital Communications]]></category>
		<category><![CDATA[global communications]]></category>
		<category><![CDATA[healthcare]]></category>
		<category><![CDATA[marketing strategy]]></category>
		<category><![CDATA[Pharma]]></category>
		<category><![CDATA[social media]]></category>

		<guid isPermaLink="false">http://www.your-story.org/?p=246382</guid>
		<description><![CDATA[SMi Group’s CPD accredited Social Media: Our Past, Present and the Future of Digital Health Online masterclass provides industry professionals with the tools needed to plan, execute and fully incorporate social media as part of your pharmaceutical firm’s effective overall online digital strategy. &#160; Social media’s potential as a tool to raise awareness in healthcare ...]]></description>
		<wfw:commentRss>http://your-story.org/social-media-our-past-present-and-the-future-of-digital-health-online-246382/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>New Pharmaceutical Marketing and Strategy in Opinion Leadership</title>
		<link>http://your-story.org/new-pharmaceutical-marketing-and-strategy-in-opinion-leadership-246381/</link>
		<comments>http://your-story.org/new-pharmaceutical-marketing-and-strategy-in-opinion-leadership-246381/#comments</comments>
		<pubDate>Tue, 07 Jun 2011 18:35:16 +0000</pubDate>
		<dc:creator>smigroup</dc:creator>
				<category><![CDATA[Pharmeceuticals]]></category>
		<category><![CDATA[challenges]]></category>
		<category><![CDATA[defining]]></category>
		<category><![CDATA[diffusion]]></category>
		<category><![CDATA[investigating]]></category>
		<category><![CDATA[leadership]]></category>
		<category><![CDATA[lifecycle]]></category>
		<category><![CDATA[marketing]]></category>
		<category><![CDATA[opinion]]></category>
		<category><![CDATA[Pharma]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[products]]></category>
		<category><![CDATA[strategy]]></category>

		<guid isPermaLink="false">http://www.your-story.org/?p=246381</guid>
		<description><![CDATA[Massive changes have occurred over the last decade in the pharmaceutical industry and have consequently led to a period of transition, which has necessitated a change in approach. The previous blockbuster model was showing cracks, and reps were no longer seen as the solution to a lot of problems. SMi’s CPD accredited Masterclass gives industry ...]]></description>
		<wfw:commentRss>http://your-story.org/new-pharmaceutical-marketing-and-strategy-in-opinion-leadership-246381/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Intellectual Property and Licensing in Biotech</title>
		<link>http://your-story.org/intellectual-property-and-licensing-in-biotech-246379/</link>
		<comments>http://your-story.org/intellectual-property-and-licensing-in-biotech-246379/#comments</comments>
		<pubDate>Tue, 07 Jun 2011 18:35:12 +0000</pubDate>
		<dc:creator>smigroup</dc:creator>
				<category><![CDATA[Pharmeceuticals]]></category>
		<category><![CDATA[Biotech]]></category>
		<category><![CDATA[cost]]></category>
		<category><![CDATA[Effectiveness]]></category>
		<category><![CDATA[fto]]></category>
		<category><![CDATA[Intellectual]]></category>
		<category><![CDATA[intelligence]]></category>
		<category><![CDATA[issues]]></category>
		<category><![CDATA[Legal]]></category>
		<category><![CDATA[licensing]]></category>
		<category><![CDATA[market]]></category>
		<category><![CDATA[Partnering]]></category>
		<category><![CDATA[Pharma]]></category>
		<category><![CDATA[property]]></category>
		<category><![CDATA[regulations]]></category>
		<category><![CDATA[strategy]]></category>

		<guid isPermaLink="false">http://www.your-story.org/?p=246379</guid>
		<description><![CDATA[For biotech ideas to be successful, the idea must be protected by an IP strategy that supports financing and partnering and that results in an IP portfolio that provides sufficient exclusivity to ensure a good return on investment. SMi Group provides a CPD accredited masterclass which helps delegates and their firms ensure IP success by ...]]></description>
		<wfw:commentRss>http://your-story.org/intellectual-property-and-licensing-in-biotech-246379/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Patent Issues in the Development of Biosimilar Medicines</title>
		<link>http://your-story.org/patent-issues-in-the-development-of-biosimilar-medicines-246378/</link>
		<comments>http://your-story.org/patent-issues-in-the-development-of-biosimilar-medicines-246378/#comments</comments>
		<pubDate>Tue, 07 Jun 2011 18:35:11 +0000</pubDate>
		<dc:creator>smigroup</dc:creator>
				<category><![CDATA[Pharmeceuticals]]></category>
		<category><![CDATA[biobetters]]></category>
		<category><![CDATA[biosimilar]]></category>
		<category><![CDATA[development]]></category>
		<category><![CDATA[issues]]></category>
		<category><![CDATA[Legal]]></category>
		<category><![CDATA[Markets]]></category>
		<category><![CDATA[medicines]]></category>
		<category><![CDATA[Patents]]></category>
		<category><![CDATA[Pharma]]></category>

		<guid isPermaLink="false">http://www.your-story.org/?p=246378</guid>
		<description><![CDATA[Biosimilar medicines are already a commercial reality in the European Union.  The U.S. Healthcare Reform legislation – with its defined pathway for the regulatory approval of follow-on biologics – should open up the U.S. market in the future, but in the meantime, the next batch of biosimilars will face other difficulties in reaching the market, ...]]></description>
		<wfw:commentRss>http://your-story.org/patent-issues-in-the-development-of-biosimilar-medicines-246378/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>CONTEXTWEB Study Finds Pharma Advertisers Can Realize Large Gains in Campaign Performance, Efficiency by Targeting Beyond Health Content</title>
		<link>http://your-story.org/contextweb-study-finds-pharma-advertisers-can-realize-large-gains-in-campaign-performance-efficiency-by-targeting-beyond-health-content-245685/</link>
		<comments>http://your-story.org/contextweb-study-finds-pharma-advertisers-can-realize-large-gains-in-campaign-performance-efficiency-by-targeting-beyond-health-content-245685/#comments</comments>
		<pubDate>Wed, 01 Jun 2011 17:53:21 +0000</pubDate>
		<dc:creator>MikeOB</dc:creator>
				<category><![CDATA[Pharmeceuticals]]></category>
		<category><![CDATA[contextual advertising]]></category>
		<category><![CDATA[CONTEXTWEB]]></category>
		<category><![CDATA[digital media]]></category>
		<category><![CDATA[online advertising]]></category>
		<category><![CDATA[online marketing]]></category>
		<category><![CDATA[Pharma]]></category>
		<category><![CDATA[pharma advertising]]></category>
		<category><![CDATA[pharma marketing]]></category>
		<category><![CDATA[pharmaceutical]]></category>
		<category><![CDATA[real-time bidding]]></category>
		<category><![CDATA[RTB]]></category>

		<guid isPermaLink="false">http://www.your-story.org/?p=245685</guid>
		<description><![CDATA[NEW YORK, N.Y., June 1, 2011 – A new Intelligence Report released today by CONTEXTWEB Inc., http://www.contextweb.com, a leading provider of integrated digital media services, reports that pharmaceutical advertisers can realize significant gains in campaign effectiveness and efficiency at scale by moving beyond a limited focus on premium health content. The report from CONTEXTWEB, entitled ...]]></description>
		<wfw:commentRss>http://your-story.org/contextweb-study-finds-pharma-advertisers-can-realize-large-gains-in-campaign-performance-efficiency-by-targeting-beyond-health-content-245685/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Middle East &amp; Africa Pharma Industry Evolving and Growing</title>
		<link>http://your-story.org/middle-east-africa-pharma-industry-evolving-and-growing-237020/</link>
		<comments>http://your-story.org/middle-east-africa-pharma-industry-evolving-and-growing-237020/#comments</comments>
		<pubDate>Tue, 05 Apr 2011 11:59:40 +0000</pubDate>
		<dc:creator>rncos</dc:creator>
				<category><![CDATA[Pharmeceuticals]]></category>
		<category><![CDATA[MEA Pharma Market]]></category>
		<category><![CDATA[MEA Pharmaceutical]]></category>
		<category><![CDATA[Pharmaceutical Market]]></category>

		<guid isPermaLink="false">http://www.your-story.org/?p=237020</guid>
		<description><![CDATA[Our latest research offering “Middle East and Africa Pharma Sector Forecast to 2012”, depicts that the pharmaceutical industry in the region is undergoing a phase of dynamic change. The changes brought about by revolutionary initiatives taken by the government of the constituent nations will help the pharma industry to grow at an unprecedented rate. Various ...]]></description>
		<wfw:commentRss>http://your-story.org/middle-east-africa-pharma-industry-evolving-and-growing-237020/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Japanese Generics Market Poised for Rapid Expansion</title>
		<link>http://your-story.org/japanese-generics-market-poised-for-rapid-expansion-232481/</link>
		<comments>http://your-story.org/japanese-generics-market-poised-for-rapid-expansion-232481/#comments</comments>
		<pubDate>Mon, 21 Feb 2011 11:51:08 +0000</pubDate>
		<dc:creator>rncos</dc:creator>
				<category><![CDATA[Pharmeceuticals]]></category>
		<category><![CDATA[Japan Generic Drug Market]]></category>
		<category><![CDATA[Japan Pharmaceutical Market by Segment]]></category>
		<category><![CDATA[Japan Pharmaceuticals Market]]></category>

		<guid isPermaLink="false">http://www.your-story.org/?p=232481</guid>
		<description><![CDATA[According to our latest report entitled “Japanese Generic Market Forecast to 2013”, the generic drugs market in Japan has been witnessing positive developments for the past few years. All the industry participants have been actively promoting the use of generic drugs across the country. Due to such positive developments, the generics market in Japan reached ...]]></description>
		<wfw:commentRss>http://your-story.org/japanese-generics-market-poised-for-rapid-expansion-232481/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

<!-- Performance optimized by W3 Total Cache. Learn more: http://www.w3-edge.com/wordpress-plugins/

Page Caching using disk: enhanced
Content Delivery Network via Amazon Web Services: CloudFront: d18wou7xwzd7x8.cloudfront.net

Served from: your-story.org @ 2012-02-14 21:50:16 -->
